International Journal of Clinical Research

Objective To analyze the role of low-dose ropivacaine and sufentanil in subarachnoid anesthesia during cesarean section. Methods Randomly and equally divide the parturients who underwent cesarean section admitted to our hospital from June 2022 to June 2024 (n=68). The experimental group received subarachnoid anesthesia with low-dose ropivacaine and sufentanil, while the control group received subarachnoid anesthesia with low-dose ropivacaine. Compare indicators such as the onset time of anesthesia. Results Regarding the onset time of anesthesia: The experimental group was only (2.31±0.41) min, while the control group was as long as (4.09±0.72) min, P < 0.05. The excellent and good rate of anesthesia: 100.0% in the experimental group and 76.47% in the control group, P < 0.05. Postpartum VAS score: The experimental group was only (4.25±1.03) points, while the control group was as high as (7.31±1.42) points, P < 0.05. Adverse reactions: The experimental group was lower than the control group (P < 0.05). Conclusion Subarachnoid anesthesia with low-dose ropivacaine and sufentanil for parturients undergoing cesarean section has a significant effect, with fewer adverse reactions, shorter onset time of anesthesia, and milder postpartum pain.

Ropivacaine; Subarachnoid anesthesia; Cesarean section; Sufentanil